What are the major opportunities in the Influenza Vaccines market? What are the strategies for the Influenza Vaccines market?

For detailed insights on the major opportunities and strategies in the Influenza Vaccines market, Read More

How does the Influenza Vaccines market relate to the overall economy and other similar markets?

For detailed insights on Influenza Vaccines's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Influenza Vaccines market growth? SWOT analysis of the Influenza Vaccines market.

For detailed insights on the key dynamics influencing the Influenza Vaccines market growth and SWOT analysis of the Influenza Vaccines industry, Read More

Influenza Vaccines Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Influenza Vaccines Market Report 2026

Name: Influenza Vaccines Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric, Adult), By Distribution Channel (Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Influenza Vaccines Market Overview

• Influenza Vaccines market size has reached to $9.04 billion in 2025

• Expected to grow to $13.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%

• Growth Driver: The Rising Incidences Of Seasonal Influenza Drive Growth In The Influenza Vaccine Market

• Market Trend: Clover Biopharmaceuticals Introduces Adimflu-S (QIS)

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Influenza Vaccines Market?

Influenza vaccines refer to flu vaccines designed to provide immunity against influenza viruses. These are quadrivalent vaccines, designed to protect against four different flu viruses, including two influenza A viruses and two influenza B viruses.

The main types of influenza vaccines are inactivated and live attenuated vaccines. An inactivated refers to a type of vaccine that contains killed or inactivated microorganisms or viruses to stimulate an immune response without causing disease and is used to prevent infection and reduce the severity of illness caused by influenza viruses. They are available as quadrivalent and trivalent and are administered as injections and nasal sprays for people aged pediatric and adult. These are distributed through hospitals and pharmacies, government and institutional supply, and other distribution channels.

Influenza Vaccines Market Global Report 2026 Market Report bar graph

What Is The Influenza Vaccines Market Size and Share 2026?

The influenza vaccines market size has grown strongly in recent years. It will grow from $9.04 billion in 2025 to $9.71 billion in 2026 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rising prevalence of seasonal influenza, limited public awareness in early 2000s, predominance of trivalent vaccines, low global manufacturing capacity, reliance on traditional egg-based production methods.

What Is The Influenza Vaccines Market Growth Forecast?

The influenza vaccines market size is expected to see strong growth in the next few years. It will grow to $13.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing adoption of quadrivalent vaccines, expansion of precision medicine approaches, growing government vaccination initiatives, development of cell-based and recombinant vaccines, enhanced cold chain and distribution infrastructure. Major trends in the forecast period include seasonal vaccine formulation optimization, expansion of pediatric immunization programs, increase in government-funded flu vaccination campaigns, adoption of novel adjuvants for enhanced immunogenicity, growth in home-based and outpatient vaccine delivery.

Book your 30 minutes free consultation with our research experts

Global Influenza Vaccines Market Segmentation

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

What Is The Driver Of The Influenza Vaccines Market?

The rising incidences of seasonal influenza are expected to propel the growth of the influenza vaccine market going forward. Seasonal influenza refers to a respiratory illness caused by influenza viruses that typically circulate and cause infections during specific times of the year, usually in the colder months. This shift has resulted from antigenic drift, population susceptibility, environmental factors, incomplete vaccine coverage, and lack of universal vaccination. Influenza vaccines help in reducing the incidences of seasonal influenza by providing immunization against the circulating strains of the virus. For example, in November 2023, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported that during the 2022-2023 flu season, there were approximately 31 million flu-related illnesses, 14 million flu-related medical visits, 360,000 flu-related hospitalizations, and 21,000 flu-related deaths. Therefore, the rising incidences of seasons of influenza are driving the growth of the influenza vaccines industry.

Key Players In The Global Influenza Vaccines Market

Major companies operating in the influenza vaccines market are Pfizer Inc., Merck & Co Inc., Sanofi-Aventis LLC, GlaxoSmithKline plc, Serum Institute of India Private Limited, Seqirus Inc., CSL Limited, Daiichi Sankyo Company Limited, Moderna Inc., Novavax AB, Bharat Biotech International Limited, Valneva SE, Shionogi & Co Ltd., Sinovac Biotech Co Ltd., Walvax Biotechnology Co Ltd., Hualan Biological Engineering Inc., China National Pharmaceutical Group Corporation, Green Cross Corporation, Mitsubishi Tanabe Pharma Corporation, Osivax, Vaxess Technologies Inc., Gamma Vaccines Pty Ltd

Global Influenza Vaccines Market Trends and Insights

Major companies operating in the influenza vaccine market are adopting advanced product innovations, such as quadrivalent seasonal influenza vaccines, to strengthen the company's respiratory vaccine franchise and financial profile. A quadrivalent seasonal influenza vaccine is designed to protect against four different flu viruses, including two influenza A viruses and two influenza B viruses. For instance, in September 2023, Clover Biopharmaceuticals Ltd., a China-based biotechnology company, launched AdimFlu-S (QIS), a quadrivalent seasonal influenza vaccine. This vaccine is the only imported quadrivalent seasonal influenza vaccine approved for use in individuals aged three years and older in China. The quadrivalent make-up of the vaccine improves its ability to achieve high vaccine effectiveness, regardless of which influenza B strain becomes seasonally prevalent, when compared to trivalent options.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Influenza Vaccines Market?

In February 2023, Clover Biopharmaceuticals, a China-based biotechnology company specializing in vaccine research, development, manufacturing, and commercialization, partnered with Adimmune Corporation to exclusively commercialize AdimFlu-S (QIS), a quadrivalent seasonal influenza vaccine, in mainland China. With this partnership, Clover aims to expand its respiratory vaccine franchise by leveraging its established commercial infrastructure to distribute a high-quality quadrivalent influenza vaccine and address growing demand in the Chinese market. Adimmune Corporation is a Taiwan-based vaccine manufacturer that develops and produces critical vaccines.

Regional Insights

North America was the largest region in the influenza vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Influenza Vaccines Market?

The influenza vaccines market consists of sales of recombinant influenza vaccines, high-dose influenza vaccines, cell-based influenza vaccines, and egg-based influenza vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Influenza Vaccines Market Report 2026?

The influenza vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the influenza vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Influenza Vaccines Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$9.71 billion
Revenue Forecast In 2035	$13.13 billion
Growth Rate	CAGR of 7.4% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Vaccine Type, Valency, Route Of Administration, Age Group, Distribution Channel
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Merck & Co Inc., Sanofi-Aventis LLC, GlaxoSmithKline plc, Serum Institute of India Private Limited, Seqirus Inc., CSL Limited, Daiichi Sankyo Company Limited, Moderna Inc., Novavax AB, Bharat Biotech International Limited, Valneva SE, Shiono
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Influenza Vaccines Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Influenza Vaccines Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Influenza Vaccines Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Influenza Vaccines Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Seasonal Vaccine Formulation Optimization

4.2.2 Expansion Of Pediatric Immunization Programs

4.2.3 Increase In Government-Funded Flu Vaccination Campaigns

4.2.4 Adoption Of Novel Adjuvants For Enhanced Immunogenicity

4.2.5 Growth In Home-Based And Outpatient Vaccine Delivery

5. Influenza Vaccines Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Government & Public Health Programs

5.4 Pharmacies

5.5 Pediatric Care Centers

6. Influenza Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Influenza Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Influenza Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Influenza Vaccines Market Size, Comparisons And Growth Rate Analysis

7.3. Global Influenza Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Influenza Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Influenza Vaccines Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Influenza Vaccines Market Segmentation

9.1. Global Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inactivated, Live Attenuated

9.2. Global Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Quadrivalent, Trivalent

9.3. Global Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Injection, Nasal Spray

9.4. Global Influenza Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric, Adult

9.5. Global Influenza Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

9.6. Global Influenza Vaccines Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

9.7. Global Influenza Vaccines Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

10. Influenza Vaccines Market Regional And Country Analysis

10.1. Global Influenza Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Influenza Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Influenza Vaccines Market

11.1. Asia-Pacific Influenza Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Influenza Vaccines Market

12.1. China Influenza Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Influenza Vaccines Market

13.1. India Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Influenza Vaccines Market

14.1. Japan Influenza Vaccines Market Overview

14.2. Japan Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Influenza Vaccines Market

15.1. Australia Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Influenza Vaccines Market

16.1. Indonesia Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Influenza Vaccines Market

17.1. South Korea Influenza Vaccines Market Overview

17.2. South Korea Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Influenza Vaccines Market

18.1. Taiwan Influenza Vaccines Market Overview

18.2. Taiwan Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Influenza Vaccines Market

19.1. South East Asia Influenza Vaccines Market Overview

19.2. South East Asia Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Influenza Vaccines Market

20.1. Western Europe Influenza Vaccines Market Overview

20.2. Western Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Influenza Vaccines Market

21.1. UK Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Influenza Vaccines Market

22.1. Germany Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Influenza Vaccines Market

23.1. France Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Influenza Vaccines Market

24.1. Italy Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Influenza Vaccines Market

25.1. Spain Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Influenza Vaccines Market

26.1. Eastern Europe Influenza Vaccines Market Overview

26.2. Eastern Europe Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Influenza Vaccines Market

27.1. Russia Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Influenza Vaccines Market

28.1. North America Influenza Vaccines Market Overview

28.2. North America Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Influenza Vaccines Market

29.1. USA Influenza Vaccines Market Overview

29.2. USA Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Influenza Vaccines Market

30.1. Canada Influenza Vaccines Market Overview

30.2. Canada Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Influenza Vaccines Market

31.1. South America Influenza Vaccines Market Overview

31.2. South America Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Influenza Vaccines Market

32.1. Brazil Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Influenza Vaccines Market

33.1. Middle East Influenza Vaccines Market Overview

33.2. Middle East Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Influenza Vaccines Market

34.1. Africa Influenza Vaccines Market Overview

34.2. Africa Influenza Vaccines Market, Segmentation By Vaccine Type, Segmentation By Valency, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Influenza Vaccines Market Regulatory and Investment Landscape

36. Influenza Vaccines Market Competitive Landscape And Company Profiles

36.1. Influenza Vaccines Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Influenza Vaccines Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Influenza Vaccines Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi-Aventis LLC Overview, Products and Services, Strategy and Financial Analysis

36.3.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Serum Institute of India Private Limited Overview, Products and Services, Strategy and Financial Analysis

37. Influenza Vaccines Market Other Major And Innovative Companies

Seqirus Inc., CSL Limited, Daiichi Sankyo Company Limited, Moderna Inc., Novavax AB, Bharat Biotech International Limited, Valneva SE, Shionogi & Co Ltd., Sinovac Biotech Co Ltd., Walvax Biotechnology Co Ltd., Hualan Biological Engineering Inc., China National Pharmaceutical Group Corporation, Green Cross Corporation, Mitsubishi Tanabe Pharma Corporation, Osivax

38. Global Influenza Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Influenza Vaccines Market

40. Influenza Vaccines Market High Potential Countries, Segments and Strategies

40.1 Influenza Vaccines Market In 2030 - Countries Offering Most New Opportunities

40.2 Influenza Vaccines Market In 2030 - Segments Offering Most New Opportunities

40.3 Influenza Vaccines Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Influenza Vaccines Market, Overview Of Key Products - Product Examples

Table 2: Global Influenza Vaccines Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Influenza Vaccines Market, Supply Chain Analysis

Table 4: Global Influenza Vaccines Market, Major Raw Material Providers

Table 5: Global Influenza Vaccines Market, Major Resource Providers

Table 6: Global Influenza Vaccines Market, Major Manufacturers (Suppliers)

Table 7: Global Influenza Vaccines Market, Major Distributors And Channel Partners

Table 8: Global Influenza Vaccines Market, Key Technologies & Future Trends

Table 9: Global Influenza Vaccines Market, Major Trends

Table 10: Global Influenza Vaccines Market, Major End Users

Table 11: Global Influenza Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Influenza Vaccines Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Influenza Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Influenza Vaccines Market - TAM, US$ Billion, 2025

Table 15: Global Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Influenza Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Influenza Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Influenza Vaccines Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Influenza Vaccines Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Influenza Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Influenza Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Influenza Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Influenza Vaccines Market - Company Scoring Matrix

Table 98: Pfizer Inc. Financial Performance

Table 99: Merck & Co Inc. Financial Performance

Table 100: Sanofi-Aventis LLC Financial Performance

Table 101: GlaxoSmithKline plc Financial Performance

Table 102: Serum Institute of India Private Limited Financial Performance

Table 103: Global Influenza Vaccines Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Influenza Vaccines Market, Competitive Dashboard

Table 105: Global Influenza Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Influenza Vaccines Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030

Table 107: Global, Influenza Vaccines Market Size Gain ($ Billion), Segmentation By Valency, 2025 – 2030

Table 108: Global, Influenza Vaccines Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Influenza Vaccines Market, Overview Of Key Products - Product Examples

Figure 2: Global Influenza Vaccines Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Influenza Vaccines Market, Supply Chain Analysis

Figure 4: Global Influenza Vaccines Market, Major Raw Material Providers

Figure 5: Global Influenza Vaccines Market, Major Resource Providers

Figure 6: Global Influenza Vaccines Market, Major Manufacturers (Suppliers)

Figure 7: Global Influenza Vaccines Market, Major Distributors And Channel Partners

Figure 8: Global Influenza Vaccines Market, Key Technologies & Future Trends

Figure 9: Global Influenza Vaccines Market, Major Trends

Figure 10: Global Influenza Vaccines Market, Major End Users

Figure 11: Global Influenza Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Influenza Vaccines Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Influenza Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Influenza Vaccines Market - TAM, US$ Billion, 2025

Figure 15: Global Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Influenza Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Influenza Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Influenza Vaccines Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Influenza Vaccines Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Influenza Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Influenza Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Influenza Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Influenza Vaccines Market, Segmentation By Valency, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Influenza Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Influenza Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Influenza Vaccines Market - Company Scoring Matrix

Figure 98: Pfizer Inc. Financial Performance

Figure 99: Merck & Co Inc. Financial Performance

Figure 100: Sanofi-Aventis LLC Financial Performance

Figure 101: GlaxoSmithKline plc Financial Performance

Figure 102: Serum Institute of India Private Limited Financial Performance

Figure 103: Global Influenza Vaccines Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Influenza Vaccines Market, Competitive Dashboard

Figure 105: Global Influenza Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Influenza Vaccines Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030

Figure 107: Global, Influenza Vaccines Market Size Gain ($ Billion), Segmentation By Valency, 2025 – 2030

Figure 108: Global, Influenza Vaccines Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Influenza Diagnostic Market Report 2026 - Global Outlook – By Traditional Diagnostic Tests (Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests ), By Molecu...

Swine Flu Vaccination Market Report 2026 - Global Outlook – By Vaccine Type (Intranasal, Toxoid, Conjugate, Inactivated Vaccine, Attenuated Vaccine, Other Vaccine Type), By Treatment Type (Influenza, Live Attenuated Infl...

Therapeutic BCG Vaccines Market Report 2026 - Global Outlook – By Type (Therapy BCG, Other Types), By Demographics (Pediatrics, Adults), By End Use (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global ...

Respiratory Disease Vaccine Market Report 2026 - Global Outlook – By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other In...

Preventive Vaccines Market Report 2026 - Global Outlook – By Type (Live Or Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines, Recombinant Vector Vaccines), By ...

Influenza Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric,...

Influenza Treatment Market Report 2026 - Global Outlook – By Product Type (Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, Other Products), By Route Of Administration (Oral, Other Routes Of Administratio...

Frequently Asked Questions

How big is the Influenza Vaccines Market?

The Influenza Vaccines market was valued at $9.04 billion in 2025, increased to $9.71 billion in 2026, and is projected to reach $13.13 billion by 2030.

What is the Influenza Vaccines market growth?

The global Influenza Vaccines market is expected to grow at a CAGR of 7.8% from 2026 to 2035 to reach $13.13 billion by 2035.

Who are the key players in Influenza Vaccines market?

Some Key Players in the Influenza Vaccines market Include, Pfizer Inc., Merck & Co Inc., Sanofi-Aventis LLC, GlaxoSmithKline plc, Serum Institute of India Private Limited, Seqirus Inc., CSL Limited, Daiichi Sankyo Company Limited, Moderna Inc., Novavax AB, Bharat Biotech International Limited, Valneva SE, Shionogi & Co Ltd., Sinovac Biotech Co Ltd., Walvax Biotechnology Co Ltd., Hualan Biological Engineering Inc., China National Pharmaceutical Group Corporation, Green Cross Corporation, Mitsubishi Tanabe Pharma Corporation, Osivax, Vaxess Technologies Inc., Gamma Vaccines Pty Ltd .

What is the anticipated growth trend for the Influenza Vaccines market?

Major trend in this market includes: Clover Biopharmaceuticals Introduces Adimflu-S (QIS). For further insights on this market. request a sample here

Which region has the most growth potential in the Influenza Vaccines market?

North America was the largest region in the influenza vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.